First National Bank of Omaha’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,369
Closed -$329K 331
2023
Q2
$329K Sell
1,369
-409
-23% -$85K 0.02% 295
2023
Q1
$334K Sell
1,778
-1,968
-53% -$407K 0.02% 294
2022
Q4
$796K Sell
3,746
-960
-20% -$192K 0.05% 233
2022
Q3
$740K Sell
4,706
-150
-3% -$23.9K 0.05% 231
2022
Q2
$727K Buy
4,856
+2,240
+86% +$324K 0.04% 239
2022
Q1
$428K Sell
2,616
-897
-26% -$148K 0.02% 286
2021
Q4
$765K Sell
3,513
-5,705
-62% -$1.19M 0.04% 253
2021
Q3
$1.75M Sell
9,218
-981
-10% -$179K 0.09% 184
2021
Q2
$1.67M Hold
10,199
0.09% 190
2021
Q1
$1.67M Sell
10,199
-1,172
-10% -$179K 0.09% 190
2020
Q4
$1.58M Sell
11,371
-229
-2% -$28.9K 0.09% 189
2020
Q3
$1.3M Sell
11,600
-69
-0.6% -$7.98K 0.08% 182
2020
Q2
$1.08M Sell
11,669
-52
-0.4% -$4.42K 0.07% 194
2020
Q1
$860K Buy
11,721
+112
+1% +$9.72K 0.07% 204
2019
Q4
$976K Buy
11,609
+314
+3% +$24.3K 0.06% 227
2019
Q3
$949K Sell
11,295
-900
-7% -$68K 0.06% 220
2019
Q2
$798K Buy
+12,195
New +$703K 0.05% 232

Other funds holding MEDP

First National Bank of Omaha's MEDP Position: Q3 2023 in Review

First National Bank of Omaha sold out of Medpace (MEDP) in Q3 2023, closing a stake of 1,369 shares — an estimated $329K sold.

First National Bank of Omaha first reported a position in MEDP in Q2 2019 and held it in 17 quarters. The position peaked at $1.75M in Q3 2021. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • First National Bank of Omaha reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
  • First National Bank of Omaha sold 1,369 Medpace shares in Q3 2023, an estimated $329K.
  • First National Bank of Omaha first reported a position in Medpace in Q2 2019 and held it in 17 quarters.
  • First National Bank of Omaha's Medpace position peaked at $1.75M in Q3 2021.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on First National Bank of Omaha's 13F filing for Q3 2023, filed 14 Nov 2023.